SCHEMBL3346669

SCHEMBL3346669

Cc1ccc(-c2ccn(C)n2)cc1C(N)=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 2/20 0.53
MKNK2 Q9HBH9 2/20 0.53
PARP1 P09874 1/20 0.49
KEAP1 Q14145 1/20 0.47
IKBKE Q14164 1/20 0.43
TBK1 Q9UHD2 1/20 0.43
PIK3CD O00329 1/20 0.43
PIP5K1C O60331 1/20 0.43
PIK3CA P42336 1/20 0.43
PIK3CB P42338 1/20 0.43
PI4KA P42356 1/20 0.43
PIK3CG P48736 1/20 0.43
PI4KB Q9UBF8 1/20 0.43
KMT2A Q03164 1/20 0.42
P2RX7 Q99572 1/20 0.42
SYK P43405 2/20 0.41
TGFBR1 P36897 3/20 0.40
JMJD6 Q6NYC1 2/20 0.39
SIRT3 Q9NTG7 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3343786 0.84 MKNK1 (0.39) MKNK1MKNK2PARP1KMT2AP2RX7
SCHEMBL3341313 0.81 HRH3 (0.43) KMT2ASYK
SCHEMBL3342117 0.81 PDE4D (0.39) MKNK1MKNK2SYKSIRT3TDP1
SCHEMBL19773733 0.77 KEAP1 (0.55) MKNK1MKNK2KEAP1PIK3CDPIP5K1C
SCHEMBL3346118 0.77 SYK (0.40) MKNK1MKNK2PARP1SYKSIRT3
SCHEMBL3343238 0.76 MEN1 (0.46) KMT2AKDM4E
SCHEMBL3346678 0.76 KEAP1 (0.59) MKNK1MKNK2KEAP1PIK3CDPIP5K1C
SCHEMBL3346285 0.75 HDAC3 (0.38) KMT2AP2RX7SYKSIRT3TDP1
SCHEMBL3347972 0.75 GPR52 (0.43) MKNK1MKNK2PIK3CBSIRT3TDP1
SCHEMBL3347858 0.74 P2RX7 (0.44) MKNK1MKNK2PARP1PIK3CBP2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 MKNK1 2405/4885MKNK2 2356/4885PARP1 1466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.